Published in AIDS Patient Care STDS on October 23, 2010
Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med (2008) 7.71
Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol (2008) 3.34
Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study. J Hepatol (2007) 2.58
Liver tumors in children. Oncologist (2008) 1.91
Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001. Arch Intern Med (2004) 1.70
Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome. AIDS (2004) 1.44
Hepatitis C virus viremia in HIV-infected individuals with negative HCV antibody tests. J Acquir Immune Defic Syndr (2002) 1.29
Evolving epidemiology of malignancies in HIV. Curr Opin Oncol (2008) 1.10
Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology group. J Clin Oncol (2002) 1.10
Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era. World J Gastroenterol (2008) 1.08
Hepatocellular carcinoma in HIV-infected patients comes of age: The convergence of epidemiology and treatment effectiveness. J Hepatol (2009) 0.95
A case of hepatocellular carcinoma in HIV-infected patient. Hepatogastroenterology (1997) 0.81
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med (2012) 52.99
Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape. Sci Transl Med (2012) 13.12
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N Engl J Med (2015) 13.08
Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell (2007) 13.04
Expression of Yes-associated protein in common solid tumors. Hum Pathol (2008) 4.61
The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev Cell (2010) 4.47
Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet (2011) 4.38
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev (2012) 4.19
Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibody. Clin Cancer Res (2012) 3.68
Comparing different measures of retention in outpatient HIV care. AIDS (2012) 1.98
Continued production of drug-sensitive human immunodeficiency virus type 1 in children on combination antiretroviral therapy who have undetectable viral loads. J Virol (2004) 1.85
The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses. J Clin Invest (2005) 1.82
Impact of disclosure of HIV infection on health-related quality of life among children and adolescents with HIV infection. Pediatrics (2009) 1.79
Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer. PLoS One (2011) 1.79
Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection. J Clin Invest (2004) 1.71
Antiretroviral treatment strategies in highly treatment experienced perinatally HIV-infected youth. Pediatr Infect Dis J (2012) 1.62
Sarcina organisms in the gastrointestinal tract: a clinicopathologic and molecular study. Am J Surg Pathol (2011) 1.61
Neonatologist training to guide family decision making for critically ill infants. Arch Pediatr Adolesc Med (2009) 1.61
Tc17 CD8 T cells: functional plasticity and subset diversity. J Immunol (2009) 1.54
The national agenda for quality palliative care: the National Consensus Project and the National Quality Forum. J Pain Symptom Manage (2007) 1.53
Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion. HPB (Oxford) (2011) 1.44
Values parents apply to decision-making regarding delivery room resuscitation for high-risk newborns. Pediatrics (2008) 1.41
Communication intervention in the neonatal intensive care unit: can it backfire? J Palliat Med (2014) 1.40
Opposing regulation of T cell function by Egr-1/NAB2 and Egr-2/Egr-3. Eur J Immunol (2008) 1.35
PD-1/PD-L1 blockade together with vaccine therapy facilitates effector T-cell infiltration into pancreatic tumors. J Immunother (2015) 1.35
Dysregulated LIGHT expression on T cells mediates intestinal inflammation and contributes to IgA nephropathy. J Clin Invest (2004) 1.28
Disparities in receipt of antiretroviral therapy among HIV-infected adults (2002-2008). Med Care (2012) 1.28
KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: implications for the human pancreatic cancer cell of origin. Mol Cancer Res (2009) 1.26
Gadd45beta promotes hepatocyte survival during liver regeneration in mice by modulating JNK signaling. J Clin Invest (2008) 1.23
Hedgehog activity, epithelial-mesenchymal transitions, and biliary dysmorphogenesis in biliary atresia. Hepatology (2011) 1.22
Variation in lymph node assessment after colon cancer resection: patient, surgeon, pathologist, or hospital? J Gastrointest Surg (2010) 1.20
Retention in care is more strongly associated with viral suppression in HIV-infected patients with lower versus higher CD4 counts. J Acquir Immune Defic Syndr (2014) 1.19
The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis. J Cell Physiol (2009) 1.18
Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility. Ann Surg (2007) 1.18
Shifting trends in liver-directed management of patients with colorectal liver metastasis: a population-based analysis. Surgery (2011) 1.17
Impact of age on retention in care and viral suppression. J Acquir Immune Defic Syndr (2015) 1.17
Yes-associated protein regulates the hepatic response after bile duct ligation. Hepatology (2012) 1.15
Sustained savings from a longitudinal cost analysis of an internet-based preapproval antimicrobial stewardship program. Infect Control Hosp Epidemiol (2013) 1.15
The hippo pathway in human upper gastrointestinal dysplasia and carcinoma: a novel oncogenic pathway. Int J Gastrointest Cancer (2006) 1.14
The critical role of LIGHT in promoting intestinal inflammation and Crohn's disease. J Immunol (2005) 1.14
The effect of neoadjuvant chemotherapy and surgery in children with malignant germ cell tumors of the genital region: a pediatric intergroup trial. J Pediatr Surg (2003) 1.13
Selective targeting of the LIGHT-HVEM costimulatory system for the treatment of graft-versus-host disease. Blood (2006) 1.12
Depth of tumor invasion better predicts prognosis than the current American Joint Committee on Cancer T classification for distal bile duct carcinoma. Surgery (2009) 1.11
Yes-associated protein 1 is widely expressed in human brain tumors and promotes glioblastoma growth. J Neuropathol Exp Neurol (2011) 1.10
Fas-positive T cells regulate the resolution of airway inflammation in a murine model of asthma. J Exp Med (2006) 1.10
Do-not-resuscitate orders and/or hospice care, psychological health, and quality of life among children/adolescents with acquired immune deficiency syndrome. J Palliat Med (2008) 1.09
Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms. Am J Surg Pathol (2010) 1.07
Perceptions, experiences, and shifts in perspective occurring among urban youth participating in a mindfulness-based stress reduction program. Complement Ther Clin Pract (2010) 1.07
Multidisciplinary, inpatient directly observed therapy for HIV-1-infected children and adolescents failing HAART: A retrospective study. AIDS Patient Care STDS (2006) 1.06
Excellent outcome in patients with stage I germ cell tumors of the testes: a study of the Children's Cancer Group/Pediatric Oncology Group. J Pediatr Surg (2003) 1.06
Health insurance coverage for persons in HIV care, 2006-2012. J Acquir Immune Defic Syndr (2014) 1.05
Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets. Ann Surg Oncol (2014) 1.02
T cell-derived lymphotoxin regulates liver regeneration. Gastroenterology (2008) 1.01
Use of a high resolution melting assay to analyze HIV diversity in HIV-infected Ugandan children. Pediatr Infect Dis J (2012) 0.99
Correlates of sexual activity and sexually transmitted infections among human immunodeficiency virus-infected youth in the LEGACY cohort, United States, 2006. Pediatr Infect Dis J (2011) 0.98
A polymeric nanoparticle formulation of curcumin (NanoCurc™) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation. Lab Invest (2011) 0.98
Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/ E2F transcription factor 1-dependent apoptotic pathway. Hepatology (2013) 0.98
Immunohistochemical staining of B7-H1 (PD-L1) on paraffin-embedded slides of pancreatic adenocarcinoma tissue. J Vis Exp (2013) 0.97
Predictive factors of malignancy in pediatric thyroid nodules. Surgery (2011) 0.97
Impact of hepatitis coinfection on hospitalization rates and causes in a multicenter cohort of persons living with HIV. J Acquir Immune Defic Syndr (2014) 0.96
Temporal trends in population-based death rates associated with chronic liver disease and liver cancer in the United States over the last 30 years. Cancer (2014) 0.94
Conformity of pediatric/adolescent HIV clinics to the patient-centered medical home care model. AIDS Patient Care STDS (2013) 0.94
Mindfulness-based stress reduction for HIV-infected youth: a pilot study. Explore (NY) (2008) 0.92
The frequency of KRAS and BRAF mutations in intrahepatic cholangiocarcinomas and their correlation with clinical outcome. Hum Pathol (2013) 0.92
Successful liver transplantation for Budd-Chiari syndrome in a patient with paroxysmal nocturnal hemoglobinuria treated with the anti-complement antibody eculizumab. Liver Transpl (2009) 0.91
Hepatotoxicity associated with dietary supplements containing anabolic steroids. Clin Gastroenterol Hepatol (2007) 0.91
Polymeric nanoparticle-encapsulated hedgehog pathway inhibitor HPI-1 (NanoHHI) inhibits systemic metastases in an orthotopic model of human hepatocellular carcinoma. Clin Cancer Res (2011) 0.90
Interdisciplinary interventions to improve pediatric palliative care and reduce health care professional suffering. J Palliat Med (2006) 0.89
Ritonavir-fluticasone interaction causing Cushing syndrome in HIV-infected children and adolescents. Pediatr Infect Dis J (2006) 0.89
Personal and professional experiences of pediatric residents concerning death. J Palliat Med (2006) 0.89
Caveolin and thrombospondin expression during hepatocellular carcinogenesis. Am J Surg Pathol (2004) 0.88
Behavior outbursts, orofacial dyskinesias, and CSF pleocytosis in a healthy child. Pediatrics (2011) 0.88
The prognostic value of stroma in pancreatic cancer in patients receiving adjuvant therapy. HPB (Oxford) (2014) 0.88
Expression of Yes-associated protein modulates Survivin expression in primary liver malignancies. Hum Pathol (2012) 0.88
Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma. Ann Surg (2016) 0.87
Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma. Pediatr Blood Cancer (2008) 0.87
Substantial multiclass transmitted drug resistance and drug-relevant polymorphisms among treatment-naïve behaviorally HIV-infected youth. AIDS Patient Care STDS (2012) 0.87
Immunostaining of plasma cells in primary biliary cirrhosis. Am J Clin Pathol (2009) 0.86
Genomic and immunophenotypical differences between hepatocellular carcinoma with and without cirrhosis. Histopathology (2010) 0.86
Autoimmune hepatitis in patients with primary Sjögren's syndrome: a series of two-hundred and two patients. Int J Clin Exp Pathol (2010) 0.85
Hilar cholangiocarcinoma: tumor depth as a predictor of outcome. Arch Surg (2011) 0.85
Antibody response to hepatitis A immunization among human immunodeficiency virus-infected children and adolescents. Pediatr Infect Dis J (2008) 0.84
Gastrointestinal ramifications of the cloacal exstrophy complex: a 44-year experience. J Pediatr Surg (2010) 0.83
Expression of glypican-3 in undifferentiated embryonal sarcoma and mesenchymal hamartoma of the liver. Hum Pathol (2011) 0.82
The role of liver-directed surgery in patients with hepatic metastasis from a gynecologic primary carcinoma. World J Surg (2011) 0.82
Prehospital predictors of risk for pelvic fractures in pediatric trauma patients. Pediatr Surg Int (2008) 0.82
Hyperplastic Luschka ducts: a mimic of adenocarcinoma in the gallbladder fossa. Am J Surg Pathol (2011) 0.81
Hepatitis in common variable immunodeficiency. Hum Pathol (2008) 0.81
Pediatric palliative care: the time has come. Arch Pediatr Adolesc Med (2002) 0.81
Trends in hospitalizations among children and young adults with perinatally acquired HIV. Pediatr Infect Dis J (2014) 0.81
"I learned that no death is routine": description of a death and bereavement seminar for pediatrics residents. Acad Med (2002) 0.81
Growth patterns in the first year of life differ in infants born to perinatally vs. nonperinatally HIV-infected women. AIDS (2015) 0.80
Thirty-day hospital readmission rate among adults living with HIV. AIDS (2013) 0.80
Bereavement debriefing sessions: an intervention to support health care professionals in managing their grief after the death of a patient. Pediatr Nurs (2010) 0.80
Thinking about HIV infection. Pediatr Rev (2009) 0.79
Brief Report: Gonorrhea and Chlamydia Testing Increasing but Still Lagging in HIV Clinics in the United States. J Acquir Immune Defic Syndr (2015) 0.79